Mold and Illness: What the Research Supports, What Remains Contested, and What It Means for Your Home
Utah Mold Pros | Indoor Air Quality | Salt Lake City, Salt Lake Valley & Utah County
This article provides general educational information. Utah Mold Pros does not diagnose illness or provide medical advice. If you have health concerns related to your indoor environment, please consult a qualified healthcare professional.
When people suspect mold is affecting their health, they often encounter two unhelpful responses. The first is dismissal: mold is everywhere, everyone is exposed, and the connection to symptoms is probably in your head. The second is the opposite extreme: confident claims about systemic illness, genetic susceptibility percentages, and specific treatment protocols stated as though they carry the same certainty as a blood pressure reading.
Neither response serves the person trying to make an informed decision about their home and their health.
The evidence on mold and health exists on a spectrum. Some of it is well-established, replicated across decades of research, and endorsed by the CDC, WHO, the Institute of Medicine, and the EPA. Some of it is emerging, contested within medicine, and the subject of ongoing research and genuine scientific debate. Treating both ends of that spectrum with the same level of confidence misrepresents what is actually known.
This post covers what the evidence supports, where it becomes less certain, and why a proper environmental assessment matters regardless of where any individual falls on that spectrum.
What the Established Research Shows
The foundational literature on indoor mold and respiratory health comes from credible, mainstream institutions and is not in dispute.
In 2004, the Institute of Medicine completed a comprehensive review of the scientific literature published as "Damp Indoor Spaces and Health." The IOM found sufficient evidence of an association between exposure to damp indoor environments and upper respiratory tract symptoms, cough, and wheeze in otherwise healthy people, asthma symptoms in people with asthma, and hypersensitivity pneumonitis in susceptible individuals. Importantly, the IOM was careful to characterize these as associations, not proven causal relationships, and specifically noted that the evidence at that time did not support broader systemic claims about indoor mold exposure.
In 2007, researchers at Lawrence Berkeley National Laboratory published a meta-analysis in the journal Indoor Air finding that indoor dampness and mold indicators were associated with approximately 30 to 50 percent increases in the occurrence of a range of respiratory health problems. A companion paper co-authored by EPA researchers used those associations to model that a significant portion of U.S. asthma cases may be related to dampness and mold exposure in the home. These are population-level estimates based on modeled associations, not proof that mold directly caused each case, but they reflect the scale of the public health concern.
In 2009, the World Health Organization issued its Guidelines for Indoor Air Quality: Dampness and Mould, concluding that moisture and mold in homes was associated with significant increases in respiratory health effects and calling for stronger standards around building moisture management.
The CDC's current position summarizes the established evidence: people who spend time in damp buildings report health problems including respiratory symptoms and infections, developing or worsening asthma, hypersensitivity pneumonitis, allergic rhinitis, and eczema. Mold can cause irritation of the eyes, nose, throat, skin, and lungs even in people who are not allergic to mold. For immunocompromised individuals and people with chronic lung disease, certain mold species can cause active fungal infections. The CDC, notably, does not endorse routine mold testing and recommends that visible mold be addressed regardless of species identification.
The evidence is clearest and most consistent for respiratory and allergic effects. These are the outcomes most thoroughly studied and most reliably confirmed across independent research programs.
How Mold Affects the Respiratory System
The mechanisms behind mold's respiratory effects are well-documented and help explain why different people respond differently to the same exposure.
Allergic response. Mold spores are potent allergens for a meaningful portion of the population. When inhaled by a sensitized individual, they can trigger responses presenting as rhinitis, nasal congestion, sneezing, red or itchy eyes, and skin irritation. These immediate hypersensitivity reactions are among the most consistently documented health effects of indoor mold exposure.
Asthma exacerbation and development. The EPA and CDC both identify mold as a recognized asthma trigger. The IOM's 2000 report, "Clearing the Air: Asthma and Indoor Air Exposures," identified mold and moisture as contributing to one of the most common chronic illnesses in American children. More recent studies have suggested a potential link between early mold exposure and asthma development in genetically susceptible children, though the causal pathway remains an area of ongoing research.
Hypersensitivity pneumonitis. This is an immune-mediated lung condition caused by repeated inhalation of organic particulates including mold spores and fungal fragments. Unlike allergic rhinitis, it affects the deep lung tissue. It presents as flu-like symptoms including fever, chills, fatigue, and shortness of breath occurring hours after exposure. Chronic hypersensitivity pneumonitis from repeated low-level exposure can cause permanent lung damage if the source is not identified and removed.
Infections in susceptible individuals. Immunocompromised individuals and those with chronic lung conditions can develop active fungal infections from certain mold species, not merely immune responses to them. Aspergillus species in particular carry infection risk in severely immunocompromised patients.
Where the Evidence Becomes Less Settled
Beyond the respiratory and allergic picture, there is a broader category of claims linking indoor mold exposure to systemic illness: fatigue, cognitive impairment, neurological symptoms, and multi-system conditions that do not resolve when the exposure ends.
These claims are where the scientific consensus becomes genuinely contested, and intellectual honesty requires saying so.
The American Academy of Allergy, Asthma & Immunology has stated that available evidence is insufficient to support the claimed relationship between inhaled indoor mycotoxins and the nonspecific systemic symptoms described under the term "toxic mold syndrome." The American College of Medical Toxicology similarly states that evidence does not support indoor inhaled mycotoxins as a cause of chronic systemic toxicity. These are major medical organizations, and their positions reflect the current state of mainstream clinical consensus.
That does not mean the patients experiencing these symptoms are not genuinely ill. It means that the scientific community has not yet reached consensus on the mechanisms, the diagnostic criteria, or the treatment approach. This is a distinction that matters both for the people experiencing these symptoms and for anyone who is going to make public claims about it.
Chronic Inflammatory Response Syndrome: A Developing Area of Medicine
Within this contested space, Chronic Inflammatory Response Syndrome, commonly called CIRS, represents one of the most discussed frameworks for understanding why some people develop persistent, multi-system illness following exposure to water-damaged buildings while others do not.
CIRS was first described by Dr. Ritchie Shoemaker beginning in the late 1990s and has since been the subject of a growing body of clinical literature. A 2024 review published in the Annals of Medicine and Surgery describes CIRS as a proposed condition involving innate immune dysregulation following exposure to water-damaged buildings, with symptoms potentially affecting multiple organ systems. The Shoemaker framework proposes that in individuals with certain HLA gene variants, the immune system does not effectively process biotoxins from mold and other organisms in water-damaged environments, leading to persistent inflammation.
It is important to be clear about what this means in practice. CIRS is recognized and actively treated by a growing group of clinicians. The Shoemaker Protocol, a structured stepwise treatment approach developed from this clinical research, is described in published literature and has practitioners who are certified in its application. A 2024 literature review found it to be the only CIRS treatment approach described in the peer-reviewed literature it evaluated, though that review encompassed a small body of published work rather than large independent randomized trials.
At the same time, CIRS is not currently an accepted diagnosis across mainstream medicine. Its proposed biomarkers, diagnostic criteria, and treatment protocols remain subjects of active research and debate. The diagnostic probability statistics sometimes cited in connection with CIRS, including symptom cluster scoring and visual contrast sensitivity testing, have not been independently validated in large representative populations to the standard required for broad clinical adoption.
The most honest framing of the current situation is this: symptomatic people deserve to be taken seriously, the proposed biological mechanisms are scientifically plausible, and a growing clinical community is actively working with these patients. But the evidence has not yet reached the level of consensus that would allow it to be presented alongside CDC and WHO findings as equally settled.
If you believe your symptoms may be related to your indoor environment, the appropriate starting point is a qualified healthcare professional who can evaluate your specific situation. Some patients and physicians find value in working within the CIRS framework. Others approach the same symptoms through different clinical lenses. That is a decision to make with your physician, not with an environmental inspection company.
What Environmental Assessment Can and Cannot Do
This is where Utah Mold Pros' role becomes relevant, and where it is worth being precise about what that role is.
An independent environmental assessment can document the presence and extent of mold growth, identify the moisture conditions driving it, characterize the fungal ecology of the indoor environment through air and surface sampling, evaluate the HVAC system as a potential reservoir and distribution mechanism, and produce a report that can be shared with treating healthcare professionals to provide environmental context for their clinical evaluation.
What an environmental assessment cannot do is diagnose illness, establish medical causation, or determine whether any individual's symptoms are attributable to conditions found in their home. That determination belongs to a physician.
For patients working with physicians who are evaluating potential environmental contributions to their health, an environmental assessment provides the building-side documentation that a physician's evaluation cannot. Whether the clinical framework being applied is a mainstream allergy evaluation, a pulmonology workup, or a CIRS protocol, understanding what is actually in the indoor environment is foundational information. If significant mold growth, elevated moisture, or compromised building conditions are present, addressing them is appropriate regardless of the clinical diagnosis.
The environmental problem and the medical problem are related but separate. Both deserve proper professional attention.
When to Seek an Environmental Assessment
The respiratory and health research, taken together, supports seeking an independent environmental assessment in several situations:
When household members are experiencing respiratory symptoms that appear to correlate with time spent in the home. When a persistent musty odor exists that cannot be sourced through visual inspection. When a water intrusion event, regardless of apparent severity, has affected building materials. When a physician requests environmental documentation as part of evaluating a patient's health concerns. When purchasing or selling a property with known or suspected moisture history. After mold remediation has been completed and clearance confirmation is needed.
The research is clear that damp, moldy buildings are a legitimate environmental health concern. What it does not tell you is whether any specific building is affecting any specific person's health. That is what a proper assessment is designed to help answer, within the limits of what environmental testing can actually establish.
Credible Resources for Further Reading
CDC Mold and Health: cdc.gov/mold-health
EPA Mold and Health: epa.gov/mold
WHO Guidelines for Indoor Air Quality: Dampness and Mould (2009): available through who.int
National Academies, "Damp Indoor Spaces and Health" (2004): available through The National Academies Press
AAAAI position on toxic mold: aaaai.org
ACMT position statement on mold-related inhalation exposures: acmt.net
Survivingmold.com: primary resource for the Shoemaker CIRS framework and physician certification information
Utah Mold Pros provides independent mold inspection, mold testing, and indoor air quality assessment throughout Salt Lake City and the Wasatch Front. Our reports can be shared with treating healthcare professionals to provide environmental context. We perform no remediation and maintain no financial relationships with remediation contractors.
Mold Inspection | Mold Testing | IAQ Testing | Clearance Testing
Call or text (385) 775-2219. Free consultations available.
ACAC Certified. Independent. No remediation. No conflicts.
